Search results for: 'Biological market'

The report explores the transformation of obesity care from generalized BMI-based treatment to AI-enabled precision metabolic management. The study highlights how obesity is increasingly recognized as a heterogeneous, multi-pathway disease influenced by genetic, neurobehavioral, metabolic, and environmental factors, requiring personalized therapeut...

10 Jan 2018  |  Asia Pacific  |  Market Research

APAC Biosimilar Market, Forecast 2025

Patent Expiries, Defined Regulatory Pathways, and Escalating Healthcare Costs to Boost Growth

Infographics

×

Key Issues Addressed Key Benefits

Biosimilars is a massive opportunity; regardless of a slow start, the market will eventually be a huge business. As per Frost & Sullivan’s estimate, biologic drugs worth $70–$80 billion will lose exclusivity in the next 5 years globally and APAC’s contribution would be more than 20%. Countries in the region, such as India, China, and South Korea, o...

23 Dec 2022  |  North America  |  Market Research

Growth Opportunities in the Vendor Neutral Archiving Solutions Industry

Large Imaging Data Silos and a Rising Number of Medical Imaging Procedures Drive the Demand for VNA

Infographics

×

This research provides an overview of the global vendor neutral archive (VNA) solutions industry, covering North America (NA), Europe, and Asia-Pacific (APAC). VNA solutions are defined as software, platform, and professional services that healthcare facilities extensively utilize to establish a repository of images and data from different picture ...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming AI-enabled discovery, precision diagnostics, cell engineering, targeted therapeutics, vaccines, and skin health across oncology, metabolic disease, rare disorders, neuropsychiatry, and ne...

In the last century, advances in the biological sciences have resulted in the sequencing of the human genome, vaccines for numerous debilitating diseases such as polio, and countless other achievements. At the center of these achievements has been, and continues to be, dependable research reagents. In this study we examine a number of key segment...

The rising global prevalence of neurodegenerative diseases (NDDs) is driving the shift from symptom-to-disease-modifying therapeutics that target unique pathological mechanisms, such as protein misfolding, neuroinflammation, and synaptic dysfunction, and customizing treatment based on unique genetic profiles, disease subtypes, and distinct biomarke...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming respiratory medicine, liver regeneration, metabolic disease management, infectious disease therapeutics, neurological disorders, cardiovascular risk reduction, oncology workflows, and nex...

01 Sep 2022  |  Global  |  Market Research

Global Single-use Flexible Endoscope Growth Opportunities

Breakthrough Technologies and Competitive Intensity Drive Innovation in the Medtech Industry

Infographics

×

The single-use endoscope is a breakthrough technology that is revolutionizing the global endoscopy space to eliminate the risk of cross-contamination among patients. Despite compliance with manufacturers' instructions, multiple outbreaks from contaminated reusable endoscopes (specifically, duodenoscopes and bronchoscopes) continue to occur. Complex...

More than 100 companies participate in the global next generation sequencing (NGS) informatics market. This research service evaluates the market from 2012 to 2018. The research covers key market drivers and restraints, analysis of the changing competitive landscape, revenue forecasts, and the important trends that affect market growth. Also includ...